Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesInsulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link?
Experimental and Clinical Cardiology, 07/02/09
Mustafa S et al. – A review focuses on epoxyeicosatrienoic acids (EETs) production, metabolism, isomerism and vasodilatory effects discusses potential mechanisms of action as well as the role of EETs in insulin secretion and sensitivity and their implication in diabetes mellitus and the metabolic syndrome. Also addressed are drugs affecting EET bioavailability and action as promising agents for treatment of hypertension/insulin resistance and the effects of these agents in experimental vascular disorders.
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Sponsor
Article Search
Sponsor
Sponsor